GlassScriptPhysician profile
Jodi A Turano
NPI 1639340599
$1,031.79
in general payments reported to CMS, 2019-2025
15 companies · $354 in 2025
The $354 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.83 · 2020: $11.38 · 2021: $318 · 2022: $228 · 2023: $32.57 · 2024: $64.09 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $451.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $603.43 | 2021-2025 | Lo Loestrin Fe, Qulipta |
| Biogen, INC. | $113.91 | 2025 | Zurzuvae, Skyclarys |
| Medtronic, INC. | $50.93 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.69 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $32.11 | 2025 | Farxiga |
| Novo Nordisk INC | $31.00 | 2024-2025 | Ozempic, Wegovy |
| Vertex Pharmaceuticals Incorporated | $29.75 | 2025 | |
| Sumitomo Pharma America, INC. | $23.11 | 2025 | Gemtesa |
| Daiichi Sankyo INC. | $20.76 | 2024 | Injectafer |
| Inspire Medical Systems, INC. | $18.99 | 2025 | Inspire |
| Stryker Corporation | $17.36 | 2025 | 1788 |
| Hologic Sales and Service, LLC | $15.22 | 2022 | |
| Dexcom, INC. | $15.03 | 2024 | Dexcom G6 Transmitter |
| Avion Pharmaceuticals | $11.38 | 2020 | |
| Exeltis, USA INC. | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jodi Turano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.